WHO expert committee on drug dependence

World Health Organization - Technical Report Series

Volumn , Issue 942, 2006, Pages 1-24

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BUTANEDIOL; 4 HYDROXYBUTYRIC ACID; AMPHETAMINE; BUPRENORPHINE; BUTORPHANOL; CANNABIS; CATHA EDULIS EXTRACT; CATHINONE; DELTA 9 HYDROCANNABINOL; DRONABINOL; GAMMA BUTYROLACTONE; KETAMINE; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; NOREPHEDRINE; NORPSEUDOEPHEDRINE; ORIPAVINE; PSYCHOTROPIC AGENT; TETRAHYDROCANNABINOL; THEBAINE; TRAMADOL; UNCLASSIFIED DRUG; ZOPICLONE;

AGITATION; ALCOHOL WITHDRAWAL; ANOREXIA; CACHEXIA; CANCER CHEMOTHERAPY; CHRONIC PAIN; CONCENTRATION LOSS; DIZZINESS; DRUG ABUSE; DRUG APPROVAL; DRUG DEPENDENCE; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; DRUG SURVEILLANCE PROGRAM; FATIGUE; HALLUCINATION; HEADACHE; HUMAN; MIGRAINE; NAUSEA; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NONHUMAN; OPIATE ADDICTION; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; SWEATING; TOXICITY; VOMITING;

4-BUTYROLACTONE; ADVISORY COMMITTEES; BUPRENORPHINE; BUTORPHANOL; CATHA; DRUG AND NARCOTIC CONTROL; DRUG EVALUATION; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYDROXYBUTYRATES; KETAMINE; PIPERAZINES; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS; TETRAHYDROCANNABINOL; THEBAINE; TRAMADOL; WORLD HEALTH ORGANIZATION;

EID: 33947387012     PISSN: 05123054     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (16)

1. Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol amending the Single Convention on Narcotic Drugs, 1961. New York, United Nations, 1972.
2. Convention on Psychotropic Substances, 1971. New York, United Nations, 1977.
3. WHO Expert Committee on Drug Dependence. Thirty-third report. Geneva, World Health Organization, 2003 (WHO Technical Report Series, No. 915).
4. WHO Expert Committee on Drug Dependence. Twenty-sixth report. Geneva, World Health Organization, 1989 (WHO Technical Report Series, No. 787).
5. WHO Expert Committee on Drug Dependence. Twenty-seventh report. Geneva, World Health Organization, 1991 (WHO Technical Report Series, No. 808).
6. Report of the thirty-fourth session (29 April-9 May 1991). Economic and Social Council, Commission on Narcotic Drugs, Official Records, 1991, Supplement No. 4. New York, United Nations, 1991 (E/1991/24, E/Cn.7/1991/26).
7. WHO Expert Committee on Drug Dependence. Thirty-second report. Geneva, World Health Organization, 2001 (WHO Technical Report Series, No. 903).
8. United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988. New York, United Nations, 1991.
9. WHO Expert Committee on Drug Dependence. Twenty-fifth report. Geneva, World Health Organization, 1989 (WHO Technical Report Series, No. 775).
10. WHO Model List of Essential Medicines, 14th edition, Geneva, World Health Organization, 2005.
11. Listing of ketamine under the Convention on Psychotropic Substances of 1971, draft resolution. Vienna, Economic and Social Council, Commission on Narcotic Drugs, 49th session, 2006 (E/CN.7/2006/L.11).
12. WHO Expert Committee on Drug Dependence. Twenty-ninth report. Geneva, World Health Organization, 1995 (WHO Technical Report Series, No. 856).
13. WHO Expert Committee on Drug Dependence. Thirty-first report. Geneva, World Health Organization, 1999 (WHO Technical Report Series, No. 887).
14. Guidelines for the WHO review of dependence-producing psychoactive substances for international control. Geneva, World Health Organization, 2000 (reprinted from document EB 105/2000/REC/1, Annex 9).
15. Summary Records: Executive Board, 114th Session. Geneva, World Health Organization, 2004.
16. Summary Records: Sixth meeting, Executive Board, 115th Session. Geneva, World Health Organization, 2005.